About HKTDC | Media Room | Contact HKTDC | Wish List Wish List () | My HKTDC |
繁體 简体
Save As PDF Print this page
Qzone

Guangdong Scraps Approvals for Cross-Location Drug Advertising and Radiopharmaceutical Use

The Food and Drug Administration of Guangdong Province will no longer be accepting applications relating to either the cross-location filing of drug advertisements or licences for the use of radiopharmaceuticals (categories I and II) within medical institutions. This procedural change specifically relates to any entity operating within the Guangdong Pilot Free Trade Zone.

For further details (in Chinese), please visit the following link:

Circular of the Guangdong Food and Drug Administration (No. 181 [2018])

Content provided by Picture: HKTDC Research
Comments (0)
Shows local time in Hong Kong (GMT+8 hours)

HKTDC welcomes your views. Please stay on topic and be respectful of other readers.
Review our Comment Policy

*Add a comment (up to 5,000 characters)